Recent News

• 03.04.2026 - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 02.26.2026 - Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
• 02.19.2026 - Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026

Recent Filings

• 02.26.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 02.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2026 - 8-K Current report
• 02.26.2026 - EX-99.1 EX-99.1
• 02.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.09.2026 - 144 Report of proposed sale of securities
• 02.09.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.09.2026 - 144 Report of proposed sale of securities
• 02.06.2026 - 4 Statement of changes in beneficial ownership of securities